Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|January 26, 2019
Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic InterventionsKatharina Rothe, Vanessa Porter, Xiaoyan JiangCells|October 15, 2025
Dual Targeting of Smoothened, a Key Regulator in the Hedgehog Pathway, and BCR-ABL1 Effectively Eradicates Drug-Insensitive Stem/Progenitor Cells in Chronic Myeloid LeukemiaKelly A Turner, Min Chen, Katharina Rothe, et al.Oncotarget|September 17, 2014
Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cellsHanyang Lin, Min Chen, Katharina Rothe, et al.Autophagy|November 9, 2013
Autophagy: from structure to metabolism to therapeutic regulationMario A Jardon, Katharina Rothe, Svetlana Bortnik, et al.Autophagy|June 9, 2020
Puncta intended: connecting the dots between autophagy and cell stress networksCally J Ho, Gayathri Samarasekera, Katharina Rothe, et al.Leukemia|August 23, 2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trialRyan Yen, Sarah Grasedieck, Andrew Wu, et al.Autophagy|August 29, 2018
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?Paalini Sathiyaseelan, Katharina Rothe, Kevin C Yang, et al.Science Translational Medicine|February 14, 2018
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemiaDamian Lai, Min Chen, Jiechuang Su, et al.Science Translational Medicine|July 19, 2019
Response to Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia"Damian Lai, Min Chen, Jiechuang Su, et al.Autophagy|October 29, 2015
Precision autophagy: Will the next wave of selective autophagy markers and specific autophagy inhibitors feed clinical pipelines?Chandra B Lebovitz, Lindsay DeVorkin, Damien Bosc, et al.Pageof 2